Fenyramidol
Muscle relaxant drug
- M03BX30 (WHO)
- 1-phenyl-2-(pyridin-2-ylamino)ethanol
- 553-69-5
Y
- 9470
- 9098
- R3V02WL7O3
- ChEMBL1697767
N
- DTXSID00862185
![Edit this at Wikidata](http://upload.wikimedia.org/wikipedia/en/thumb/8/8a/OOjs_UI_icon_edit-ltr-progressive.svg/10px-OOjs_UI_icon_edit-ltr-progressive.svg.png)
- Interactive image
- C1=CC=CC(=C1)C(CNC2=NC=CC=C2)O
InChI
- InChI=1S/C13H14N2O/c16-12(11-6-2-1-3-7-11)10-15-13-8-4-5-9-14-13/h1-9,12,16H,10H2,(H,14,15)
- Key:ZEAJXCPGHPJVNP-UHFFFAOYSA-N
![☒](http://upload.wikimedia.org/wikipedia/commons/thumb/a/a2/X_mark.svg/7px-X_mark.svg.png)
![check](http://upload.wikimedia.org/wikipedia/en/thumb/f/fb/Yes_check.svg/7px-Yes_check.svg.png)
Fenyramidol (INN) or phenyramidol (BAN, USAN), trade name Cabral, is a pharmaceutical drug which acts as a muscle relaxant.[1]
Drug Interactions
Fenyramidol inhibits the metabolism of phenytoin, leading to possible increases in plasma phenytonin levels.[2]
References
- ^ O'Dell TB (March 1960). "Pharmacology of phenyramidol (IN511) with emphasis on analgesic and muscle-relaxant effects". Annals of the New York Academy of Sciences. 86 (1): 191–202. Bibcode:1960NYASA..86..191O. doi:10.1111/j.1749-6632.1960.tb42799.x. PMID 14428054.
- ^ Patsalos, P. N. (2013). Antiepileptic drug interactions : a clinical guide (2nd ed.). London: Springer. p. 245. ISBN 978-1-4471-2434-4. OCLC 820958181.
- v
- t
- e
Skeletal muscle relaxants (M03)
(primarily antinicotinic,
NMJ block)
Non-depolarizing |
| ||||
---|---|---|---|---|---|
Depolarizing |
| ||||
ACh release inhibitors |
![]() | This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e